Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesParacentesis in Ovarian Cancer: A Study of the Physiology during Free Drainage of Ascites
Journal of Palliative Medicine, 11/30/09
Decruze SB et al. – Ascites is frequently seen in patients suffering with ovarian cancer. Paracentesis is a well–established method to provide symptomatic relief. Systemic adverse effects have occurred in paracentesis for ascites arising from other conditions. This study has shown that paracentesis is both effective and safe as an outpatient procedure for managing malignancy–related ascites.
Related Articles
Malignant Ascites Symptom Cluster in Patients Referred for Paracentesis
Annals of Surgical Oncology, 11/02/09
Relevance Score: 80%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
Cancer Research, 03/19/10
Bitter Melon (Momordica charantia) Extract Inhibits Breast Cancer Cell Proliferation by Modulating Cell Cycle Regulatory Genes and Promotes Apoptosis
Cancer Research, 03/19/10
Late presentation of a mucinous ovarian adenocarcinoma which was initially diagnosed as a primary pancreatic carcinoma: a case report and review of the literature
Journal of Medical Case Reports, 03/19/10
Article Search
Sponsor
Sponsor